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Megalomycin C, a natural macrolide antibiotic showed a potent antiherpetic activity. At concentrations that efficiently 
prevented HSV-I multiplication, the compound had no cytotoxic or antiprohferative ffects. Viral DNA and protein syn- 
thesis took place at normal levels in the presence of the antibiotic, suggesting that neither the translation of viral mRNA, 
nor the synthesis of viral nucleic acids was affected. The incorporation of mannosc and galactosamine into viral proteins 
was blocked and precursor, but not mature, HSV-I glycoproteins were detected in the presence of megalomycin C. Non- 
infectious HSV-I viral particles were formed when the compound was present, but their glycoproteins were not properly 
glycosylated. 
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1. INTRODUCTION 
Glycosylation inhibitors have been devised as 
potential antiviral agents [ 1,2]. Although all such 
compounds interfere with the correct glycosylation 
of proteins, the effect on different viruses varies 
[3-111. In fowl plague virus the glycoproteins syn- 
thesized in the presence of tunicamycin are degrad- 
ed by proteases [5]. Underglycosylated G protein 
of vesicular stomatitis virus is not transported to 
the membrane and the egress of new virions is 
diminished [6]. Similarly, virions of Semliki Forest 
and Sindbis virus do not incorporate immature 
proteins [5,7]. With other viruses, such as influen- 
za, some virion particles are formed in the presence 
of glycosylation inhibitors, but their glycoproteins 
are underglycosylated [8]. The absence of mature 
glycoproteins does not block the assembly of new 
herpes simplex virions [4,9-111. Moreover, the 
viral particles thus formed are able to bind to and 
enter cells. However, these virions are non- 
infectious since they do not decapsidate [l]. In a 
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search for new antiviral agents we found that 
megalomycin C, a macrolide antibiotic produced 
by Micromonospora megalomicea, showed a good 
antiviral activity against herpes simplex virus type 
1 (HSV-1) and swine fever virus [3,~12]. In this 
report we describe the mode of action of 
megalomycin C against HSV-1. 
2. MATERIALS AND METHODS 
2.1. Cells and viruses 
The source and propagation of HeLa cells and HSV-1 virus 
have been described [3,13]. To measure cell growth lo5 HeLa 
cells per well were seeded in 24well plates. Where appropriate 
cells were infected with HSV-1 at a multiplicity of 10 PFU per 
cell. Then, megalomycin C was immediately added and cells 
were incubated at 37°C as described in scctio 
1 
3. Cells were 
trypsinized and viable cells were counted by the, rypan blue ex- 
elusion test in a Neubauer hemocytometer. ~ 
2.2. Analysis of proteins by polyacrylamide geIielectrophoresis 
After incubation of cells in methionine-free imedium in the 
presence of 100 &i of [“Slmethionine per ml for the period of 
time indicated in each experiment he proteins were analyzed as 
described [13]. To analyze the glycoproteins cells were in- 
cubated for the period of time indicated in 
medium without glucose in the presence of 1 
[6-‘Hlglucosamine (35 Ci/mmol), or 
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(45 Ci/mmol), or D-[6-‘Hlgalactose (30 Ci/mmol) per ml (all 
purchased from the Radiochemical Centre, Amersham). Label- 
ing and sample preparation for electrophoresis were carried out 
as described 1131. 
2.3. Purification of radiolabeled HS V-l particles 
HeLa cells were infected with HSV-1 at 10 PFU/ml. At 10 h 
post infection megalomycin C was added and the cells labeled 
with [35S]methionine (5 &i/ml), or [3H]glucosamine 
(20 &i/ml). At 20 h post infection, the cells were harvested, 
disrupted as described above, and then centrifuged at 15 000 x 
g for 10 min. Supernatants were layered onto a cushion con- 
taining 3 ml of 30% sucrose in 50 mM Tris-HCl, pH 7.4, 
0.85% NaCl and centrifuged at 40000 rpm in a Sorvall Ti65 
rotor. Pellets were dissolved in 50 ~1 of sample buffer, and elec- 
trophoresis was done as described above. 
2.4. Dot-blot analysis of HSV-I DNA 
HeLa cells were grown in 60 mm dishes and infected with 
HSV-1 at 30 PFU/ml. After 16 h of infection, infected cells 
were collected and the DNA isolated as described [14]. Two- 
fold dilutions of total DNA were spotted on a nitrocellulose 
filter and hybridized to a nick-translated “P-labeled pBR332 
fragment, containing an EcoRI fragment which includes the TK 
gene of HSV-1. This plasmid was generously provided by Dr E. 
Tabards (Madrid, Spain). Conditions for hybridization were 
described [15]. 
3. RESULTS 
The presence of 10pM megalomycin C in the 
culture medium inhibited the replication of HSV-1 
in HeLa cells as observed by the prevention of the 
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disruption of the cell monolayer (fig. 1A). 50 ,uM 
megalomycin C fully prevented the cell monolayer 
from destruction by HSV-1 when the multiplicity 
of infection was lower than 0.5 PFU/cell, sug- 
gesting that this compound blocks the production 
of a new infectious virus. At these concentrations 
it had no cytotoxic effects as determined by phase- 
contrast microscopy and produced very little in- 
hibition of protein synthesis in control cells even 
after 2 days of incubation (fig. 1A). The reduction 
of infectious HSV-1 was about 2 logs ‘in the 
presence of 50 ,uM megalomycin C (fig.lB). At 
these concentrations cell proliferation was only 
slightly reduced over a 3-day period (fig.lC). 
Addition of megalomycin C from the beginning 
of HSV-1 infection had no inhibitory effect on the 
expression of viral proteins, since they appeared at 
the same time as in the absence of this antibiotic 
(fig.2A). This result suggested that neither viral 
protein synthesis nor viral mRNA synthesis was af- 
fected by megalomycin C. The synthesis of DNA 
was also analyzed, even 100 FM megalomycin C 
did not prevent HSV-1 DNA replication (fig.2B). 
The glycosylation of proteins in the presence of 
50 ,uM of megalomycin C was analyzed by the in- 
corporation of several radioactive sugars. This 
compound had no effect on translation when add- 
ed at the same time as the radioactive methionine 
. 
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Fig.1. Antiherpetic and anticellular effects of megalomycin C. (A) Effect of different concentrations of megalomycin C on the 
cytopathic effect (CPE) induced by HSV-1 infection of HeLa cells (10.5 PFU/cell) at 48 h post infection (A). - , + - , + + , + + + 
represent CPE on a progressive scale ( + + + is the maximum). Protein synthesis was measured as indicated in section 2 in uninfected 
HeLa cells (0) and in HSV-1 infected cells (0). (B) Production of infectious HSV-1 in a multistep growth cycle in the presence of 
several concentrations of megalomycin C. (C) Proliferation of infected and noninfected cells in the presence of megalomycin C. (-) 
Uninfected cells; (- - -) cells infected with HSV-1 at high multiplicity (10 PFU/cell); (0) untreated cells; (0) cells treated with 
50 ,zM megalomycin C from the beginning of infection. h.p.i., hours post infection. 
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Fig.2. Effect of megalomycin C on the viral protein synthesis and viral DNA synthesis. (A) Time course of protein synthesis in HeLa 
cells infected with 10 PFU/ml HSV-1 in the presence (+) or absence (-) of 100 ,uM megalomycin C from the beginning of infection. 
Proteins were labeled with [%3]methionine at the indicated hours post infection (h.p.i.). (B) Effect of megalomycin C on HSV-I DNA. 
Total cellular DNA from control cells (- ) or cells incubated with 10 and 100 pM megalomycin C was hybridized to the TK radioactive 
probe as described in section 2. 
(fig.3). Moreover, no inhibition was observed on 
either protein synthesis or protein glycosylation in 
uninfected HeLa cells (fig.3). However, it com- 
pletely blocked the incorporation of mannose and 
galactose to viral proteins. Furthermore, the incor- 
poration of [3H]glucosamine into the mature 
glycoproteins gC, gB and gD was also inhibited, 
although less effect was found on the incorpora- 
tion into the precursor forms PC, pB and pD. As 
expected, the precursor forms were glycoproteins 
rich in mannose, whereas the mature forms con- 
tained galactose. Finally, viral particles were la- 
beled with [3SS]methionine, [3H]glucosamine or 
[3H]galactose and their proteins analyzed by 
polyacrylamide gel electrophoresis. Fig.4 shows 
that the [35S]methionine label in HSV-1 viral pro- 
teins was similar in the presence or absence of 
megalomycin C, but the sugar radioactivity was 
lower in non-infectious particles obtained from 
megalomycin-treated cells. Some galactose label- 
ing appeared in this preparation in the presence of 
megalomycin C, perhaps because it was concen- 
trated by centrifugation. These results agree with 
previous observations obtained with other in- 
hibitors [4,9-111 and suggest that HSV-1 non- 
infectious particles could be formed in the presence 
of the antibiotic, and their glycoproteins are 
underglycosylated. 
4. DISCUSSION 
The data presented in this contribution suggest 
that the mature forms of viral glycoproteins were 
decreased in the presence of megalomycin C, 
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Fig.3. Protein synthesis and protein glycosylation in HSV-1 infected HeLa cells in the presence (+) or absence (-) of 50 pM 
megalomycin C analyzed by SDS-PAGE. HSV-1 infected cells were labeled between 15 to 17 h post infection with [“S]methionine 
(Met), [‘H]glucosamine (GlcN), [‘Hlmannose (Man) or [‘Hlgalactose (Gal). Megalomycin C was added 1 h before and maintained 
during the labeling period. HeLa control cells were incubated in the presence of 50,~M megalomycin C (+) and in absence of the 
compound (-). Host proteins were labeled with [‘HIamino acid mixture (Aa), [‘H]glucosamine (GlcN), t3H]mannose (Man) and 
[‘Hlgalactose (Gal). 
whereas the glycoprotein precursors were present. Glycosylation inhibitors have been devised as 
These results could indicate that the trimming of potential antiviral agents [ 11. However, the most 
glycoproteins is the step blocked by megalomycin active members of this group of inhibitors, as 
C. However, this is not so clear because mannose- tunicamycin and streptovirudines, are very toxic to 
rich glycoproteins are synthesized in the presence cells [ 16,171. Other glycosylation inhibitors such as 
of trimming inhibitors, whereas megalomycin C 2-deoxyglucose or glucosamine show little selec- 
blocked the addition of mannose residues to the tivity and decrease virus production in culture cells 
proteins. More probably, this compound may in- only at millimolar concentrations [3,4]. In this 
hibit the formation, or the transfer of oligosac- respect, our finding that megalomycin C acts on 
charides from the lipid donor (dolichol-phosphate) glycosylation and shows a potent antiviral activity 
to the nascent peptide chain. Studies with cell-free is of particular interest. The antiherpetic activity of 
systems will be necessary to decide between these megalomycin C is most probably based on the for- 
possibilities. mation of underglycosylated viral proteins. 
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Fig.4. Analysis of proteins and glycoproteins of HSV-1 purified 
virions. MET, virions obtained from [%]methionine labeled 
infected cells; - , from untreated cells; + , from cells treated I 
with 50pM megalomycin C. The GLCN panels show 
[3H]glucosamine incorporation. The GAL panels show 
[‘Hlgalactose incorporation. 
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